S&P 500 7,723.39 ▲ 46.62 (+0.61%) DOW 52,389.06 ▲ 27.48 (+0.05%) NASDAQ 26,480.43 ▲ 311.05 (+1.19%) US Markets Closed â€ĸ 12:06 AM ET

STTK

Shattuck Labs, Inc.

Price Chart
Latest Quote

$5.77

+0.23 (+4.15%)
Current Price
Previous Close $5.54
Open $5.55
Day High $5.81
Day Low $5.48
Volume 699,500
Fetched: 2026-10-28T00:15:01
Stock Information
Shares Outstanding 100.36M
Total Debt $2.67M
Cash Equivalents $208.30M
Revenue $1.00M
Net Income $-52.57M
Sector Healthcare
Industry Biotechnology
Market Cap $579.10M
EPS (TTM) $-0.47
Exchange NMS
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$373.47M
Sales$1.00M
Income$-52.57M
Book/sh$2.10
Cash/sh$2.08
Employees40
Financial Ratios
Quick Ratio26.94
Current Ratio27.59
Debt/Eq1.27
Returns & Margins
ROA-24.43%
ROE-39.21%
Operating Margin-5570.50%
Ownership
Insider Ownership4.08%
Institutional Ownership80.47%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-11.16
P/S579.10
P/B2.75
Analyst Data
Recommendationstrong_buy
Target Price$15.40
Technical Indicators
SMA20$5.85
SMA50$6.39
SMA200$6.02
RSI52.13
ATR0.3734
Shares Float67.76M
Short Float11.30%
Short Ratio8.22
Volatility1.10
Rel Volume0.52
Performance History
Week-1.20%
Month-10.26%
Quarter-14.64%
6 Months-23.37%
YTD+55.53%
Year+200.52%
3 Years+312.14%
5 Years-70.81%
10 Years-70.18%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-10-27 $5.77 699,500
2026-10-26 $5.54 706,100
2026-10-23 $5.49 700,500
2026-10-22 $5.60 1,220,800
2026-10-21 $5.58 1,198,100
2026-10-20 $5.84 1,555,700
2026-10-19 $5.37 869,600
2026-10-16 $5.42 648,500
2026-10-15 $5.53 867,800
2026-10-14 $5.33 1,202,900
2026-10-13 $5.49 1,576,800
2026-10-12 $6.09 1,024,500
2026-10-09 $5.97 1,049,400
2026-10-08 $5.66 2,486,600
2026-10-07 $5.66 1,109,300
2026-10-06 $5.86 1,595,400
2026-10-05 $6.50 1,239,400
2026-10-02 $6.73 1,843,600
2026-10-01 $6.84 2,022,300
2026-09-30 $6.82 3,356,700
2026-09-29 $6.54 956,600
2026-09-28 $6.43 976,900
About Shattuck Labs, Inc.

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas.

📰 Latest News
No news articles available at the moment. Check back later for updates on STTK.
Period:
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $1,000,000 $5,721,000 $1,657,000 $652,000
Operating Revenue $1,000,000 $5,721,000 $1,657,000 $652,000
Expenses
Total Expenses $52,508,000 $86,288,000 $93,614,000 $103,981,000
Other Income Expense $-4,000 $-17,000 $-10,000 $-208,000
Other Non Operating Income Expenses $-4,000 $-17,000 $-10,000 $-208,000
Net Non Operating Interest Income Expense $2,703,000 $5,174,000 $4,669,000 $1,592,000
Operating Expense $52,508,000 $86,288,000 $93,614,000 $103,981,000
General And Administrative Expense $17,235,000 $19,077,000 $19,304,000 $21,082,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Net Interest Income $2,703,000 $5,174,000 $4,669,000 $1,592,000
Interest Income $2,703,000 $5,174,000 $4,669,000 $1,592,000
Normalized Income $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Net Income From Continuing And Discontinued Operation $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Total Operating Income As Reported $-51,508,000 $-80,567,000 $-91,957,000 $-103,329,000
Net Income Common Stockholders $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Net Income $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Net Income Including Noncontrolling Interests $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Net Income Continuous Operations $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Pretax Income $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Interest Income Non Operating $2,703,000 $5,174,000 $4,669,000 $1,592,000
Operating Income $-51,508,000 $-80,567,000 $-91,957,000 $-103,329,000
Per Share
Diluted EPS $-0.70 $-1.49 $-2.05 $-2.41
Basic EPS $-0.70 $-1.49 $-2.05 $-2.41
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-47,820,000 $-76,738,000 $-87,915,000 $-100,256,000
Reconciled Depreciation $3,688,000 $3,829,000 $4,042,000 $3,073,000
EBITDA (Bullshit earnings) $-47,820,000 $-76,738,000 $-87,915,000 $-100,256,000
EBIT $-51,508,000 $-80,567,000 $-91,957,000 $-103,329,000
Diluted Average Shares $69,584,937 $50,758,290 $42,600,190 $42,378,895
Basic Average Shares $69,584,937 $50,758,290 $42,600,190 $42,378,895
Diluted NI Availto Com Stockholders $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Research And Development $35,273,000 $67,211,000 $74,310,000 $82,899,000
Selling General And Administration $17,235,000 $19,077,000 $19,304,000 $21,082,000
Other Gand A $17,235,000 $19,077,000 $19,304,000 $21,082,000
Fetched: 2026-10-23
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $82,390,000 $79,626,000 $144,705,000 $176,157,000
Total Assets $91,026,000 $91,049,000 $159,564,000 $205,324,000
Total Non Current Assets $8,551,000 $11,834,000 $16,344,000 $20,740,000
Other Non Current Assets $1,437,000 $2,022,000 $2,540,000 $3,069,000
Current Assets $82,475,000 $79,215,000 $143,220,000 $184,584,000
Other Current Assets $4,410,000 $6,228,000 $12,595,000 $23,304,000
Cash Cash Equivalents And Short Term Investments $78,065,000 $72,987,000 $130,625,000 $161,280,000
Cash And Cash Equivalents $54,192,000 $57,387,000 $125,626,000 $47,379,000
Prepaid Assets - - - -
Debt
Total Debt $2,421,000 $3,406,000 $4,202,000 $4,903,000
Long Term Debt And Capital Lease Obligation $1,584,000 $2,506,000 $3,406,000 $4,202,000
Current Debt And Capital Lease Obligation $837,000 $900,000 $796,000 $701,000
Liabilities
Total Liabilities Net Minority Interest $8,636,000 $11,423,000 $14,859,000 $29,167,000
Total Non Current Liabilities Net Minority Interest $1,584,000 $2,506,000 $3,406,000 $4,202,000
Current Liabilities $7,052,000 $8,917,000 $11,453,000 $24,965,000
Other Current Liabilities $236,000 $410,000 $1,041,000 $1,871,000
Payables And Accrued Expenses $3,212,000 $5,319,000 $5,822,000 $18,426,000
Payables $2,101,000 $2,419,000 $1,587,000 $7,170,000
Accounts Payable $2,101,000 $2,419,000 $1,587,000 $7,170,000
Non Current Deferred Liabilities - - - $0
Current Deferred Liabilities - - - -
Equity
Common Stock Equity $82,390,000 $79,626,000 $144,705,000 $176,157,000
Total Equity Gross Minority Interest $82,390,000 $79,626,000 $144,705,000 $176,157,000
Stockholders Equity $82,390,000 $79,626,000 $144,705,000 $176,157,000
Gains Losses Not Affecting Retained Earnings $6,000 $2,000 $4,000 $-877,000
Other Equity Adjustments $6,000 $2,000 $4,000 $-877,000
Retained Earnings $-430,529,000 $-381,720,000 $-306,310,000 $-219,012,000
Long Term Equity Investment $1,000,000 $0 - -
Other
Ordinary Shares Number $63,279,843 $47,714,708 $47,260,108 $42,390,586
Share Issued $63,279,843 $47,714,708 $47,260,108 $42,390,586
Tangible Book Value $82,390,000 $79,626,000 $144,705,000 $176,157,000
Invested Capital $82,390,000 $79,626,000 $144,705,000 $176,157,000
Working Capital $75,423,000 $70,298,000 $131,767,000 $159,619,000
Capital Lease Obligations $2,421,000 $3,406,000 $4,202,000 $4,903,000
Total Capitalization $82,390,000 $79,626,000 $144,705,000 $176,157,000
Additional Paid In Capital $512,906,000 $461,339,000 $451,006,000 $396,041,000
Capital Stock $7,000 $5,000 $5,000 $5,000
Common Stock $7,000 $5,000 $5,000 $5,000
Long Term Capital Lease Obligation $1,584,000 $2,506,000 $3,406,000 $4,202,000
Current Capital Lease Obligation $837,000 $900,000 $796,000 $701,000
Pensionand Other Post Retirement Benefit Plans Current $2,767,000 $2,288,000 $3,794,000 $3,967,000
Current Accrued Expenses $1,111,000 $2,900,000 $4,235,000 $11,256,000
Investments And Advances $1,000,000 $0 - -
Net PPE $6,114,000 $9,812,000 $13,804,000 $17,671,000
Accumulated Depreciation $-16,674,000 $-13,217,000 $-9,506,000 $-5,709,000
Gross PPE $22,788,000 $23,029,000 $23,310,000 $23,380,000
Leases $6,877,000 $7,097,000 $7,097,000 $7,086,000
Other Properties $15,267,000 $15,288,000 $15,469,000 $15,547,000
Machinery Furniture Equipment $644,000 $644,000 $644,000 $643,000
Properties $0 $0 $0 $0
Other Short Term Investments $23,873,000 $15,600,000 $4,999,000 $113,901,000
Construction In Progress - $0 $100,000 $104,000
Non Current Deferred Revenue - - - -
Current Deferred Revenue - - - -
Fetched: 2026-10-23
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-39,953,000 $-60,574,000 $-81,635,000 $-106,112,000
Operating Activities
Operating Cash Flow $-39,882,000 $-60,515,000 $-81,228,000 $-94,498,000
Cash Flow From Continuing Operating Activities $-39,882,000 $-60,515,000 $-81,228,000 $-94,498,000
Operating Gains Losses $81,000 $222,000 $303,000 $704,000
Investing Activities
Capital Expenditure $-71,000 $-59,000 $-407,000 $-11,614,000
Investing Cash Flow $-7,887,000 $-8,511,000 $110,859,000 $49,438,000
Cash Flow From Continuing Investing Activities $-7,887,000 $-8,511,000 $110,859,000 $49,438,000
Financing Activities
Issuance Of Capital Stock $44,475,000 - $48,170,000 $0
Financing Cash Flow $44,574,000 $787,000 $48,616,000 $171,000
Cash Flow From Continuing Financing Activities $44,574,000 $787,000 $48,616,000 $171,000
Net Other Financing Charges $-65,000 $-451,000 $-53,000 -
Net Common Stock Issuance $44,475,000 $-17,000 $48,170,000 $0
Common Stock Issuance $44,475,000 - $48,170,000 $0
Repurchase Of Capital Stock - $-17,000 - -
Net Preferred Stock Issuance - - - -
Preferred Stock Issuance - - - -
Other
End Cash Position $54,192,000 $57,387,000 $125,626,000 $47,379,000
Beginning Cash Position $57,387,000 $125,626,000 $47,379,000 $92,268,000
Changes In Cash $-3,195,000 $-68,239,000 $78,247,000 $-44,889,000
Proceeds From Stock Option Exercised $164,000 $1,255,000 $499,000 $171,000
Net Investment Purchase And Sale $-7,816,000 $-8,452,000 $111,266,000 $60,948,000
Sale Of Investment $35,600,000 $85,100,000 $190,999,000 $193,325,000
Purchase Of Investment $-43,416,000 $-93,552,000 $-79,733,000 $-132,377,000
Net PPE Purchase And Sale $-71,000 $-59,000 $-407,000 $-11,510,000
Purchase Of PPE $-71,000 $-59,000 $-407,000 $-11,614,000
Change In Working Capital $-785,000 $3,021,000 $-4,095,000 $-4,464,000
Change In Other Current Liabilities $-922,000 $-900,000 $-796,000 $-702,000
Change In Other Current Assets $79,000 $90,000 $165,000 $-53,000
Change In Payables And Accrued Expense $-1,760,000 $-2,536,000 $-13,922,000 $133,000
Change In Accrued Expense $-1,442,000 $-3,368,000 $-8,293,000 $2,975,000
Change In Payable $-318,000 $832,000 $-5,629,000 $-2,842,000
Change In Account Payable $-318,000 $832,000 $-5,629,000 $-2,842,000
Change In Prepaid Assets $1,818,000 $6,367,000 $10,458,000 $-3,842,000
Other Non Cash Items $-599,000 $428,000 $364,000 $302,000
Stock Based Compensation $6,995,000 $9,546,000 $6,939,000 $6,462,000
Amortization Of Securities $-453,000 $-2,151,000 $-1,483,000 $1,370,000
Depreciation Amortization Depletion $3,688,000 $3,829,000 $4,042,000 $3,073,000
Depreciation And Amortization $3,688,000 $3,829,000 $4,042,000 $3,073,000
Depreciation $3,688,000 $3,829,000 $4,042,000 $3,073,000
Net Income From Continuing Operations $-48,809,000 $-75,410,000 $-87,298,000 $-101,945,000
Common Stock Payments - $-17,000 - -
Sale Of PPE - - $0 $104,000
Change In Other Working Capital - - $343,000 -
Fetched: 2026-10-23